Search Articles

View query in Help articles search

Search Results (1 to 7 of 7 Results)

Download search results: CSV END BibTex RIS


A Technology System to Help People With Intellectual Disability and Blindness Find Room Destinations During Indoor Traveling: Case Series Study

A Technology System to Help People With Intellectual Disability and Blindness Find Room Destinations During Indoor Traveling: Case Series Study

A total of 7 participants with severe to profound intellectual disability and blindness were involved in the study. The participants were 6 men and 1 woman, who represented a convenience sample [40], shared the same difficulties in orienting and traveling in indoor areas (eg, in finding room destinations, see below), and attended rehabilitation and care centers.

Giulio E Lancioni, Gloria Alberti, Chiara Filippini, Nirbhay N Singh, Mark F O’Reilly, Jeff Sigafoos, Isabella Orlando, Lorenzo Desideri

JMIR Rehabil Assist Technol 2024;11:e65680

Red Blood Cell Transfusion for Incidence of Retinopathy of Prematurity: Prospective Multicenter Cohort Study

Red Blood Cell Transfusion for Incidence of Retinopathy of Prematurity: Prospective Multicenter Cohort Study

Retinopathy of prematurity (ROP) is a retinal vasoproliferative disease that occurs in premature and low-birth-weight infants and is the most common cause of blindness and low vision in infants [1,2]. Early detection and treatment are essential for preventing irreversible visual impairment and blindness. The main pathophysiological factor in ROP is an imbalance between proangiogenic and antiangiogenic factors released locally in the retina, resulting in abnormal neovascularization [3].

Xiaoling Wang, Rui Rao, Hua Li, Xiaoping Lei, Wenbin Dong

JMIR Pediatr Parent 2024;7:e60330

Patient-Centered Economic Burden of Exudative Age-Related Macular Degeneration: Retrospective Cohort Study

Patient-Centered Economic Burden of Exudative Age-Related Macular Degeneration: Retrospective Cohort Study

Anti–vascular endothelial growth factors (VEGFs) have demonstrated remarkable efficacy in averting blindness, converting once unavoidably blinding conditions into chronic diseases [1]. Anti-VEGFs are currently suggested as the primary treatment for exudative AMD [2], and 5 anti-VEGF agents (ie, ranibizumab, aflibercept, brolucizumab, bevacizumab, and faricimab) are clinically accessible.

Kyungseon Choi, Sang Jun Park, Sola Han, Yongseok Mun, Da Yun Lee, Dong-Jin Chang, Seok Kim, Sooyoung Yoo, Se Joon Woo, Kyu Hyung Park, Hae Sun Suh

JMIR Public Health Surveill 2023;9:e49852

Comparing Telephone Survey Responses to Best-Corrected Visual Acuity to Estimate the Accuracy of Identifying Vision Loss: Validation Study

Comparing Telephone Survey Responses to Best-Corrected Visual Acuity to Estimate the Accuracy of Identifying Vision Loss: Validation Study

Vision loss and blindness affect approximately 7.08 million Americans and cost the US economy US $134 billion per year [1,2]. Improving and targeting public health and medical interventions to reduce this burden depend on measuring changes in vision loss and blindness prevalence over time at the national, state, and local level.

John Wittenborn, Aaron Lee, Elizabeth A Lundeen, Phoebe Lamuda, Jinan Saaddine, Grace L Su, Randy Lu, Aashka Damani, Jonathan S Zawadzki, Colin P Froines, Jolie Z Shen, Timothy-Paul H Kung, Ryan T Yanagihara, Morgan Maring, Melissa M Takahashi, Marian Blazes, David B Rein

JMIR Public Health Surveill 2023;9:e44552

Impact of Intersecting Systems of Oppression on Diabetic Retinopathy Screening Among Those Who Identify as Women of Low Socioeconomic Status: Protocol for a Convergent Mixed Methods Study

Impact of Intersecting Systems of Oppression on Diabetic Retinopathy Screening Among Those Who Identify as Women of Low Socioeconomic Status: Protocol for a Convergent Mixed Methods Study

Diabetic retinopathy is the primary vision complication caused by diabetes [3] and is the leading cause of new cases of blindness in adults aged 20 to 65 years [4]. The prevalence of diabetic retinopathy in Canada ranges from 20% to 30% [4]. Over a million people from Ontario were affected by diabetic retinopathy in 2016 [5].

Aleksandra Stanimirovic, Troy Francis, Anna Cooper Reed, Sonia Meerai, Olivera Sutakovic, Rebecca Merritt, Michael Brent, Valeria Rac

JMIR Res Protoc 2021;10(3):e23492

A Newly Developed Web-Based Resource on Genetic Eye Disorders for Users With Visual Impairment (Gene.Vision): Usability Study

A Newly Developed Web-Based Resource on Genetic Eye Disorders for Users With Visual Impairment (Gene.Vision): Usability Study

Inherited retinal diseases are the most common causes of severe visual impairment registration among working adults in England and Wales, whereas globally, 60% of blindness among infants is due to genetic diseases [15,16]. To fill this void, we are developing a new web-based resource for these conditions with information written in 2 formats: one using more lay terms for patients and families, while the other has more technical details tailored toward health care professionals.

Jian Lee Yeong, Peter Thomas, James Buller, Mariya Moosajee

J Med Internet Res 2021;23(1):e19151